These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 15542199)

  • 1. The burden and cost of hospitalised varicella and zoster in Australian children.
    Carapetis JR; Russell DM; Curtis N
    Vaccine; 2004 Dec; 23(6):755-61. PubMed ID: 15542199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology.
    Goldman GS
    Vaccine; 2005 May; 23(25):3349-55. PubMed ID: 15837242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of Varicella-Zoster Virus in England and Wales.
    Brisson M; Edmunds WJ
    J Med Virol; 2003; 70 Suppl 1():S9-14. PubMed ID: 12627480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013.
    Hobbelen PH; Stowe J; Amirthalingam G; Miller L; van Hoek AJ
    J Infect; 2016 Sep; 73(3):241-53. PubMed ID: 27283754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella-zoster virus infection in Romanian children infected with the human immunodeficiency virus.
    Leibovitz E; Cooper D; Giurgiutiu D; Coman G; Straus I; Orlow SJ; Lawrence R
    Pediatrics; 1993 Dec; 92(6):838-42. PubMed ID: 7901834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-consequence models for varicella-zoster virus infections.
    Paul JE; Mauskopf JA; Bell L
    Pharmacotherapy; 1995; 15(5 Pt 2):49S-58S. PubMed ID: 8577631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of varicella-related hospitalisations in an Italian paediatric hospital: comparison with possible vaccination expenses.
    Azzari C; Massai C; Poggiolesi C; Indolfi G; Spagnolo G; De Luca M; Gervaso P; de Martino M; Resti M
    Curr Med Res Opin; 2007 Dec; 23(12):2945-54. PubMed ID: 17937842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infections caused by Varicella Zoster virus in children with cancer aged less than 15 years old].
    Folatre I; Zolezzi P; Schmidt D; Marín F; Täger M
    Rev Med Chil; 2003 Jul; 131(7):759-64. PubMed ID: 14513696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.
    Civen R; Chaves SS; Jumaan A; Wu H; Mascola L; Gargiullo P; Seward JF
    Pediatr Infect Dis J; 2009 Nov; 28(11):954-9. PubMed ID: 19536039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
    Wutzler P; Neiss A; Banz K; Goertz A; Bisanz H
    Med Microbiol Immunol; 2002 Oct; 191(2):89-96. PubMed ID: 12410347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of children hospitalized with herpes zoster in Canada: Immunization Monitoring Program, Active (IMPACT), 1991-2005.
    Wootton SH; Law B; Tan B; Mozel M; Scheifele DW; Halperin S;
    Pediatr Infect Dis J; 2008 Feb; 27(2):112-8. PubMed ID: 18174867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella vaccination in Australia.
    Macartney KK; Beutels P; McIntyre P; Burgess MA
    J Paediatr Child Health; 2005 Nov; 41(11):544-52. PubMed ID: 16398834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia.
    Carville KS; Riddell MA; Kelly HA
    Vaccine; 2010 Mar; 28(13):2532-8. PubMed ID: 20117265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.
    Leung TF; Chik KW; Li CK; Lai H; Shing MM; Chan PK; Lee V; Yuen PM
    Bone Marrow Transplant; 2000 Jan; 25(2):167-72. PubMed ID: 10673675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.
    Jean-Jasmin LM; Lynette SP; Stefan M; Kai CS; Chew FT; Wah LB
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):693-6. PubMed ID: 15689089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
    Wood SM; Shah SS; Steenhoff AP; Rutstein RM
    Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
    Goldman GS
    Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complications in children with varicella in 4 hospitals in Santiago, Chile: clinical spectrum and estimation of direct costs].
    Abarca K; Hirsch T; Potin M; Perret C; Zamorano J; González C; Vial P
    Rev Med Chil; 2001 Apr; 129(4):397-404. PubMed ID: 11413992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.